NCT06486220View on ClinicalTrials.gov

PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial.

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG

Intestinal bacteria freeze-dried powder capsules

Oral healthy intestinal bacteria freeze-dried powder capsules, tid

All Listed Sponsors

lead

Yun-fei Xia

OTHER